Avidity Biosciences Cash Flow Statement 2018-2024 | RNA

Fifteen years of historical annual cash flow statements for Avidity Biosciences (RNA).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-212.22$-174.00$-118.01$-44.36$-24.73$-11.22
$-9.17$0.77$0.82$0.38$0.42$0.46
$41.20$29.89$17.74$4.52$7.45$0.43
$32.03$30.66$18.55$4.91$7.87$0.89
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$56.22$-13.50$-7.19$-5.26$17.91$-0.24
$61.13$7.07$4.64$2.33$19.36$0.67
$-119.06$-136.27$-94.81$-37.12$2.49$-9.66
$-4.23$-2.82$-3.74$-1.09$-0.24$-0.05
$0$0$0$0$0$0
$0$0$0$0$0$0
$-125.84$-187.13$-78.78$-6.69$0$0
$0$0$0$0$0$0
$-125.84$-187.13$-78.78$-6.69$0$0
$0$0$0$0$0$0
$-130.07$-189.96$-82.52$-7.79$-0.24$-0.05
$0$0$0$-4.68$16.65$4.98
$0$0$0$0$0$0
$0$0$0$-4.68$16.65$4.98
$93.86$346$176$275$0.07$0.16
$93.86$346$176$277$72.69$0.16
$0$0$0$0$0$0
$0$0$0$0$-0.11$0
$93.86$346$176$272$89.23$5.14
$-155.27$19.95$-1.01$227$91.49$-4.56
$38.22$27.14$17.06$4.31$0.41$0.06
$0$0$0$0$0$0